Over the past five years, diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has made meaningful progress on ...
The global Network Point Of Care Glucose Testing Industry is set to achieve a significant value, reaching USD 1.6 billion in ...
NNC2215, a glucose-sensitive insulin, offers improved glycemic control by dynamically adjusting to blood sugar levels, ...
GEORGIA AVENUE, WA, UNITED STATES, October 18, 2024 /EINPresswire / -- The latest competent intelligence report published by Vantage <a ta ...
Novo Nordisk scientists have synthesised an insulin molecule that specifically targets glucose in blood, instead of other ...
According to Professor Partha Kar, National Specialty Advisor, Diabetes, NHS England and co-lead of Diabetes GIRFT, NHS ...
The global market for diabetes care devices is forecast to reach US $16 billion by 2030 with a growing compound annual growth rate (CAGR) of 6.5% during the forecast period 2021-2030. In 2020, the ...
Australian Declan Irvine (Team Novo Nordisk) is a bit wary of the 'big' elements at Big Sugar Gravel this Saturday. He's ...
Abbott Laboratories has reported sales of $10.6bn for the third quarter (Q3) of 2024, as against $10.4bn in Q2 2024, with ...